458 related articles for article (PubMed ID: 26537674)
1. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
[TBL] [Abstract][Full Text] [Related]
2. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
[TBL] [Abstract][Full Text] [Related]
3. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
[TBL] [Abstract][Full Text] [Related]
4. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
[TBL] [Abstract][Full Text] [Related]
5. Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.
Moustafa RI; Haddad JG; Linna L; Hanoulle X; Descamps V; Mesalam AA; Baumert TF; Duverlie G; Meuleman P; Dubuisson J; Lavie M
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068644
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
[TBL] [Abstract][Full Text] [Related]
7. Critical interaction between E1 and E2 glycoproteins determines binding and fusion properties of hepatitis C virus during cell entry.
Douam F; Dao Thi VL; Maurin G; Fresquet J; Mompelat D; Zeisel MB; Baumert TF; Cosset FL; Lavillette D
Hepatology; 2014 Mar; 59(3):776-88. PubMed ID: 24038151
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Potent and Broad-Spectrum Hepatitis C Virus Fusion Inhibitory Peptide from the E2 Stem Domain.
Chi X; Niu Y; Cheng M; Liu X; Feng Y; Zheng F; Fan J; Li X; Jin Q; Zhong J; Li YP; Yang W
Sci Rep; 2016 Apr; 6():25224. PubMed ID: 27121372
[TBL] [Abstract][Full Text] [Related]
9. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes.
Ndongo-Thiam N; Berthillon P; Errazuriz E; Bordes I; De Sequeira S; Trépo C; Petit MA
Hepatology; 2011 Aug; 54(2):406-17. PubMed ID: 21520209
[TBL] [Abstract][Full Text] [Related]
10. Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.
Marnata C; Saulnier A; Mompelat D; Krey T; Cohen L; Boukadida C; Warter L; Fresquet J; Vasiliauskaite I; Escriou N; Cosset FL; Rey FA; Lanford RE; Karayiannis P; Rose NJ; Lavillette D; Martin A
J Virol; 2015 Dec; 89(23):12131-44. PubMed ID: 26401036
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.
Ciczora Y; Callens N; Penin F; Pécheur EI; Dubuisson J
J Virol; 2007 Mar; 81(5):2372-81. PubMed ID: 17166909
[TBL] [Abstract][Full Text] [Related]
12. Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
McKeating JA; Zhang LQ; Logvinoff C; Flint M; Zhang J; Yu J; Butera D; Ho DD; Dustin LB; Rice CM; Balfe P
J Virol; 2004 Aug; 78(16):8496-505. PubMed ID: 15280458
[TBL] [Abstract][Full Text] [Related]
13. Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4
Skardasi G; Chen AY; Michalak TI
J Virol; 2018 Feb; 92(3):. PubMed ID: 29167333
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.
Tarr AW; Urbanowicz RA; Hamed MR; Albecka A; McClure CP; Brown RJ; Irving WL; Dubuisson J; Ball JK
J Virol; 2011 May; 85(9):4246-57. PubMed ID: 21325403
[TBL] [Abstract][Full Text] [Related]
15. Functional expression and characterization of the envelope glycoprotein E1E2 heterodimer of hepatitis C virus.
Cao L; Yu B; Kong D; Cong Q; Yu T; Chen Z; Hu Z; Chang H; Zhong J; Baker D; He Y
PLoS Pathog; 2019 May; 15(5):e1007759. PubMed ID: 31116791
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding.
Rothwangl KB; Manicassamy B; Uprichard SL; Rong L
Virol J; 2008 Mar; 5():46. PubMed ID: 18355410
[TBL] [Abstract][Full Text] [Related]
17. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
[TBL] [Abstract][Full Text] [Related]
18. Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
Durand T; Di Liberto G; Colman H; Cammas A; Boni S; Marcellin P; Cahour A; Vagner S; Féray C
Gut; 2010 Jul; 59(7):934-42. PubMed ID: 20442199
[TBL] [Abstract][Full Text] [Related]
19. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.
Lavillette D; Pécheur EI; Donot P; Fresquet J; Molle J; Corbau R; Dreux M; Penin F; Cosset FL
J Virol; 2007 Aug; 81(16):8752-65. PubMed ID: 17537855
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.
Xu Y; Martinez P; Séron K; Luo G; Allain F; Dubuisson J; Belouzard S
J Virol; 2015 Apr; 89(7):3846-58. PubMed ID: 25609801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
